Insulin signaling in PCOS/PMOS: molecular insights and clinical implications
Insulin signaling in polycystic ovary syndrome (PCOS) or Polyendocrine Metabolic Ovarian Syndrome (PMOS) involves selective pathway alterations that link metabolic disease to reproductive pathology. In metabolic pathways, impaired PI3K/Akt signaling limits insulin-dependent GLUT4-mediated glucose intake, while ovarian...